Published in Br J Surg on January 01, 2008
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg (2008) 2.45
Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg (2007) 1.46
Extent of surgical resections for intraductal papillary mucinous neoplasms. World J Gastrointest Surg (2010) 0.97
Intraductal Papillary Mucinous Neoplasm of Pancreas. N Am J Med Sci (2015) 0.97
Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas. World J Gastrointest Oncol (2010) 0.95
Laparoscopic versus open enucleation for pancreatic neoplasms: clinical outcomes and pancreatic function analysis. Surg Endosc (2015) 0.92
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol (2013) 0.88
Pancreatic enzyme replacement therapy: exocrine pancreatic insufficiency after gastrointestinal surgery. HPB (Oxford) (2009) 0.84
Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB (Oxford) (2012) 0.83
Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors. Langenbecks Arch Surg (2014) 0.82
Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. HPB (Oxford) (2013) 0.82
Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery. Surg Endosc (2013) 0.80
Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors. World J Surg (2016) 0.79
Risk factors for pancreatogenic diabetes after pancreaticoduodenectomy. Korean J Hepatobiliary Pancreat Surg (2012) 0.79
Laparoscopic fenestration of pancreatic serous cystadenoma: Minimally invasive approach for symptomatic benign disease. World J Gastroenterol (2015) 0.78
Postoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor. World J Surg (2016) 0.77
Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation. J Gastrointest Surg (2015) 0.77
Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB (Oxford) (2013) 0.77
Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review. World J Surg (2016) 0.77
A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival. Oncotarget (2016) 0.77
Diagnosing exocrine pancreatic insufficiency after surgery: when and which patients to treat. HPB (Oxford) (2009) 0.76
Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC Med (2017) 0.75
Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas. World J Gastroenterol (2016) 0.75
Conservative resection for benign tumors of the proximal pancreas. World J Gastroenterol (2009) 0.75
Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. HPB (Oxford) (2016) 0.75
Does the pancreatic volume reduction rate using serial computed tomographic volumetry predict new onset diabetes after pancreaticoduodenectomy? Medicine (Baltimore) (2017) 0.75
Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience. HPB (Oxford) (2015) 0.75
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75
Clear cell "sugar" tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol (1996) 3.23
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig Surg (2001) 2.08
Enucleation of pancreatic neoplasms. Br J Surg (2007) 1.88
Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum (1991) 1.80
Intraductal mucin-producing tumors of the pancreas: imaging findings. Radiology (1996) 1.70
Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer. Br J Surg (2010) 1.68
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant. Br J Cancer (2009) 1.68
Cystic dystrophy of the duodenal wall: radiologic findings. Radiology (1997) 1.62
Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci (1999) 1.59
The relevance of gastrointestinal fistulae in clinical practice: a review. Gut (2001) 1.58
High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg (2003) 1.53
Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg (2001) 1.53
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma. Ann Oncol (2005) 1.49
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol (2013) 1.47
Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-associated pancreatitis. J Clin Gastroenterol (2000) 1.42
Changes in pancreatic resection for chronic pancreatitis over 28 years in a single institution. Br J Surg (2000) 1.40
Low incidence of proteinuria in RA after gold thiosulfate treatment. J Rheumatol (1990) 1.38
Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res (1996) 1.33
Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol (1999) 1.24
Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology (1998) 1.23
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol (2008) 1.23
Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg (1998) 1.22
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. Endocr Relat Cancer (2006) 1.22
Pancreatic cystic tumors. Minerva Chir (2004) 1.21
Collagen type I synthesized by pancreatic periacinar stellate cells (PSC) co-localizes with lipid peroxidation-derived aldehydes in chronic alcoholic pancreatitis. J Pathol (2000) 1.20
High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res (2001) 1.20
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut (2005) 1.20
Long-term follow-up of patients with chronic pancreatitis in Italy. Scand J Gastroenterol (1998) 1.15
The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res (1999) 1.15
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. Br J Surg (2012) 1.10
Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis. Digestion (2001) 1.10
Successful xenografting of cryopreserved primary pancreatic cancers. Virchows Arch (2001) 1.07
Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death Differ (2008) 1.07
Behavior of antibiotics during human necrotizing pancreatitis. Antimicrob Agents Chemother (1994) 1.06
Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol (1995) 1.05
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. World J Surg (2009) 1.05
Immunodeficiency in different histotypes of radically operable gastrointestinal cancers. J Exp Clin Cancer Res (2004) 1.04
Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. Surg Gynecol Obstet (1986) 1.04
Long-term outcome of acute necrohemorrhagic pancreatitis. A 4-year follow-up. Digestion (1984) 1.03
Spontaneous rupture of renal leiomyosarcoma in a 45-year-old woman. Arch Esp Urol (2004) 1.02
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. Dig Liver Dis (2008) 1.02
Cigarette smoking: an independent risk factor in alcoholic pancreatitis. Pancreas (1996) 0.99
Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features. Histol Histopathol (2012) 0.99
The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis (1992) 0.99
Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. Abdom Imaging (2005) 0.98
Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions. Eur J Radiol (2010) 0.98
Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma. Int J Radiat Oncol Biol Phys (2001) 0.95
Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. Dig Dis Sci (1995) 0.95
Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors. J Endocrinol Invest (2004) 0.94
Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. FASEB J (2000) 0.94
Outcome of open necrosectomy in acute pancreatitis. Pancreatology (2003) 0.94
Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma. Eur J Radiol (2012) 0.94
Prevalence of alcohol and drugs in urine of patients involved in road accidents. J Prev Med Hyg (2008) 0.94
Outcome and quality of life in chronic pancreatitis. JOP (2001) 0.94
A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer. Pancreas (1988) 0.93
Duodenal duplication in the adult: its relationship with pancreatitis. Gastrointest Radiol (1988) 0.93
Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy. J Rheumatol (1992) 0.92
Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor? Ultrasound Med Biol (2009) 0.92
The fecal chymotrypsin photometric assay in the evaluation of exocrine pancreatic capacity. Comparison with other direct and indirect pancreatic function tests. Pancreas (1989) 0.92
Risk of death from acute pancreatitis. Role of early, simple "routine" data. Int J Pancreatol (1996) 0.92
Laparoscopic assisted duodenopancreatectomy. Surg Endosc (2004) 0.91
Human-derived cell lines to study xenobiotic metabolism. Chemosphere (1998) 0.91
Thoracic complications of pancreatitis. Pancreas (1989) 0.91
Endovascular treatment of arterial bleeding in patients with pancreatitis. Pancreatology (2007) 0.91
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. Digestion (1997) 0.90
Surgical strategy in the treatment of gastrointestinal neuroendocrine tumours. Ann Oncol (2001) 0.89
Prophylaxis for septic complications in acute necrotizing pancreatitis. J Hepatobiliary Pancreat Surg (2001) 0.89
[4 cases of Horton's temporal arteritis. Hypothesis on the possible correlations with rheumatic polymyalgia]. Recenti Prog Med (1994) 0.88
Solitary fibrous tumor of the prostate. J Urol (2002) 0.88
Serum creatinine and chest radiographs in the early assessment of acute pancreatitis. Am J Surg (1999) 0.88
Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours. Dig Surg (1999) 0.88
Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group. Digestion (1994) 0.88
High-affinity monomeric 67-kD laminin receptors and prognosis in pancreatic endocrine tumours. J Pathol (1997) 0.88
Reproductive phenological patterns of cerrado plant species at the Pé-de-Gigante Reserve (Santa Rita do Passa Quatro, SP, Brazil): a comparison between the herbaceous and woody floras. Rev Bras Biol (2000) 0.88
Prospective comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg (1993) 0.88
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact. Cytopathology (2013) 0.87
Cell therapy strategies and improvements for muscular dystrophy. Cell Death Differ (2009) 0.86
Pancreatic abscess and other pus-harboring collections related to pancreatitis: a review of 108 cases. World J Surg (1990) 0.85
Cystic "feminine" pancreatic neoplasms in men. Do any clinical alterations correlate with these uncommon entities? Int J Surg (2012) 0.85